Psoriatic arthritis (PsA) most often attacks and damages ... The more severe your PsA symptoms, the more likely you will have gum inflammation. Dental implants are part of the treatment for ...

Misuse of screening tools and subsequent underdiagnosis of the condition can easily occur, even amongst specialists.

There is no cure for juvenile psoriatic arthritis, but it can go into remission if treated early. Treatment can help control inflammation, prevent pain and joint damage, and reduce skin symptoms.

Ensuring a balance between these types of oils may improve arthritis symptoms. Tip ... There’s no reason to go through a psoriatic arthritis diagnosis or long-term journey alone.

Stagnant sales for Bristol Myers Squibb’s Sotyktu have raised questions about whether the tyrosine kinase 2 (TYK2) inhibitor ...

Differences in how men and women manifest and experience psoriatic arthritis suggest it’s time to think of patient sex as a ...

Bristol Myers on Monday said the two Phase 3 studies met their primary endpoint, with a significantly greater proportion of Sotyktu-treated patients achieving at least a 20% improvement in signs and ...

(RTTNews) - Drug maker Bristol-Myers Squibb Co. (BMY) Monday announced positive topline results from two pivotal Phase 3 trials evaluating Sotyktu (deucravacitinib) in adults with active psoriatic ...

Topline data were announced from two phase 3 trials evaluating deucravacitinib, a tyrosine kinase 2 (TYK2) inhibitor, in adults with active psoriatic arthritis (PsA). POETYK PsA-1 (ClinicalTrials.gov ...

Long-term treatment with guselkumab is associated with sustained improvements in joint/skin symptoms and disease activity among patients with active PsA.

A research team from the University of Central Florida's College of Medicine conducted a study of patient perceptions of ...